EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial

Nima Vaziri, Melika Shakourifar, Parinaz Sattari, Aliereza Sadeghi iD, Mehran Sharifi, Ayda Moghadas, Azadeh Moghaddas iD

Iranian Journal of Pharmaceutical Research · 06.01.2025 · 23 (1)

DOI: 10.5812/ijpr-156581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 06.01.2025. Verfasst von Nima Vaziri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfaha…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hormone therapy is commonly used to treat breast cancer but can cause mood disorders and sleep disturbances, negatively impacting patients' well-being.

Objectives

This trial aimed to evaluate the effects of melatonin on sleep problems and mood changes in breast cancer patients undergoing hormone therapy.

Methods

The study was conducted at Omid Hospital in Isfahan, Iran, using a randomized, double-blinded, placebo-controlled design. Participants were assessed using the Hospital Anxiety and Depression Scale (HADS) and were randomly assigned to receive either 6 mg of melatonin or a placebo daily for 4 weeks. Sleep quality, depression levels, and mood states were measured using the Pittsburgh Sleep Quality Index (PSQI), the Center for Epidemiological Studies-Depression Scale (CES-D), and the Profile of Mood States (POMS) Questionnaires at the beginning and end of the 4-week follow-ups.

Results

Sixty participants (34 in the melatonin group and 26 in the placebo group) completed the study. Melatonin administration significantly improved sleep quality, latency, duration, and reduced the use of sleep-promoting medication, according to the PSQI scores. However, there were no significant improvements in depression severity or mood disorders, as assessed by the CES-D and POMS questionnaires, in either group following the 4-week melatonin supplementation period.

Conclusions

Melatonin supplementation effectively alleviated sleep disturbances caused by hormone therapy in breast cancer patients. However, the study did not find substantial evidence supporting the use of melatonin for improving mood disorders or depression in this specific context.

Schlagwörter

Stichwörter der Autor:innen

Breast CancerDepressionDyssomniasHormone TherapyMelatoninMood DisorderPsycho-Oncology

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Internal Medicine, Cancer Prevention Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Isfahan, Iran.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.

ORCID-Profile: Aliereza Sadeghi, Azadeh Moghaddas

Zitieren

APA

Vaziri, N., Shakourifar, M., Sattari, P., Sadeghi, A., Sharifi, M., Moghadas, A., & Moghaddas, A. (2025). Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial. Iranian Journal of Pharmaceutical Research, 23(1). https://doi.org/10.5812/ijpr-156581

Vancouver

Vaziri N, Shakourifar M, Sattari P, Sadeghi A, Sharifi M, Moghadas A, et al. Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial. Iranian Journal of Pharmaceutical Research. 2025;23(1). doi:10.5812/ijpr-156581

BibTeX
@article{Vaziri2025,
  author = {Vaziri, Nima and Shakourifar, Melika and Sattari, Parinaz and Sadeghi, Aliereza and Sharifi, Mehran and Moghadas, Ayda and Moghaddas, Azadeh},
  title = {Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2025},
  volume = {23},
  number = {1},
  doi = {10.5812/ijpr-156581}
}
Kostenlos starten →